Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

ABSTRACT:

Purpose

To describe morphologic and visual outcomes in eyes with angiographic cystoid macular edema (CME) treated with ranibizumab or bevacizumab for neovascular age-related macular degeneration (nAMD).

Design

Prospective cohort study within a randomized clinical trial.

Participants

A total of 1185 CATT study subjects.

Methods

Baseline fluorescein angiography (FA) images of all CATT study eyes were evaluated for CME. Grading of other characteristics on optical coherence tomography (OCT) and photographic images at baseline and during 2-year follow-up was completed by readers at the CATT Reading Centers. Three groups were created on the basis of baseline CME and intraretinal fluid (IRF) status: (1) CME, (2) IRF without CME, (3) neither CME nor IRF.

Main outcom

SUBMITTER: Shah N 

PROVIDER: S-EPMC4808340 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature